Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


03.07.2017

20 AIDS
3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 HIV Med
9 J Acquir Immune Defic Syndr
1 J Infect Dis
3 J Virol
1 JAMA
1 Nature
3 Pediatr Infect Dis J
1 Pediatrics
1 PLoS Med
12 PLoS One
1 PLoS Pathog
1 Science
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. CAMACHO-GONZALEZ AF, Gillespie SE, Thomas-Seaton L, Frieson K, et al
    The Metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, Georgia, USA.
    AIDS. 2017;31 Suppl 3:S267-S275.
    PubMed     Text format     Abstract available

  2. MORSE CG
    Fatty liver disease in HIV: common, underappreciated, and understudied.
    AIDS. 2017;31:1633-1635.
    PubMed     Text format    

  3. HOORNENBORG E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, et al
    MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
    AIDS. 2017;31:1603-1610.
    PubMed     Text format     Abstract available

  4. RUPEREZ M, Gonzalez R, Maculuve S, Quinto L, et al
    Maternal HIV infection is an important health determinant in non-HIV-infected infants.
    AIDS. 2017;31:1545-1553.
    PubMed     Text format     Abstract available

  5. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017;31:1519-1528.
    PubMed     Text format     Abstract available

  6. LEE JS, Cole SR, Richardson DB, Dittmer DP, et al
    Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001573.
    PubMed     Text format     Abstract available

  7. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing PMTCT regimens.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001569.
    PubMed     Text format     Abstract available

  8. GATANAGA H, Brumme ZL, Adland E, Reyes-Teran G, et al
    Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001575.
    PubMed     Text format     Abstract available

  9. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of post-migration HIV acquisition within nine European countries.
    AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001571.
    PubMed     Text format     Abstract available

  10. RONIT A, Ahlstrom MG
    Publication trends during the HIV pandemic: contributions by country.
    AIDS. 2017;31:1646-1647.
    PubMed     Text format    

  11. HAALAND RE, Martin A, Holder A, Fountain JJ, et al
    Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis.
    AIDS. 2017;31:1647-1650.
    PubMed     Text format    

  12. WONG VJ, Murray KR, Phelps BR, Vermund SH, et al
    Adolescents, young people, and the 90-90-90 goals: a call to improve HIV testing and linkage to treatment.
    AIDS. 2017;31 Suppl 3:S191-S194.
    PubMed     Text format     Abstract available

  13. MARANO MR, Stein R, Williams WO, Wang G, et al
    HIV testing in nonhealthcare facilities among adolescent MSM.
    AIDS. 2017;31 Suppl 3:S261-S265.
    PubMed     Text format     Abstract available

  14. RURIA EC, Masaba R, Kose J, Woelk G, et al
    Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection.
    AIDS. 2017;31 Suppl 3:S253-S260.
    PubMed     Text format     Abstract available

  15. WAGNER AD, Mugo C, Bluemer-Miroite S, Mutiti PM, et al
    Continuous quality improvement intervention for adolescent and young adult HIV testing services in Kenya improves HIV knowledge.
    AIDS. 2017;31 Suppl 3:S243-S252.
    PubMed     Text format     Abstract available

  16. KAUFMAN MR, Dam KH, Van Lith LM, Hatzold K, et al
    Voluntary medical male circumcision among adolescents: a missed opportunity for HIV behavioral interventions.
    AIDS. 2017;31 Suppl 3:S233-S241.
    PubMed     Text format     Abstract available

  17. SHANAUBE K, Schaap A, Chaila MJ, Floyd S, et al
    Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study.
    AIDS. 2017;31 Suppl 3:S221-S232.
    PubMed     Text format     Abstract available

  18. WILSON KS, Beima-Sofie KM, Moraa H, Wagner AD, et al
    "At our age, we would like to do things the way we want: " a qualitative study of adolescent HIV testing services in Kenya.
    AIDS. 2017;31 Suppl 3:S213-S220.
    PubMed     Text format     Abstract available

  19. INDRAVUDH PP, Sibanda EL, d'Elbee M, Kumwenda MK, et al
    'I will choose when to test, where I want to test': investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe.
    AIDS. 2017;31 Suppl 3:S203-S212.
    PubMed     Text format     Abstract available

  20. DENISON JA, Pettifor A, Mofenson LM, Kasedde S, et al
    Youth engagement in developing an implementation science research agenda on adolescent HIV testing and care linkages in sub-Saharan Africa.
    AIDS. 2017;31 Suppl 3:S195-S201.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  21. YOSHINO Y, Koga I, Seo K, Kitazawa T, et al
    The clinical value of cystatin C as a marker of renal function in HIV patients receiving dolutegravir.
    AIDS Res Hum Retroviruses. 2017 Jun 25. doi: 10.1089/AID.2017.0074.
    PubMed     Text format     Abstract available

  22. SHACKLETT BL, Derdeyn CA, Folayan MO, Landovitz R, et al
    HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
    AIDS Res Hum Retroviruses. 2017 Jun 24. doi: 10.1089/AID.2017.0125.
    PubMed     Text format     Abstract available

  23. SHIEH EC, Weld ED, Fuchs EJ, Hiruy H, et al
    Lubricant Provides Poor Rectal Mucosal HIV Coverage.
    AIDS Res Hum Retroviruses. 2017 Jun 25. doi: 10.1089/AID.2016.0318.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  24. CHAN CN, Trinite B, Levy DN
    Potent inhibition of HIV-1 replication in resting CD4 T cells by resveratrol and pterostilbene.
    Antimicrob Agents Chemother. 2017 Jun 26. pii: AAC.00408.
    PubMed     Text format     Abstract available


    HIV Med

  25. WANG X, Nwokolo N, Korologou-Linden R, Hill A, et al
    InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    HIV Med. 2017 Jun 28. doi: 10.1111/hiv.12528.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  26. VERDERY AM, Siripong N, Pence BW
    Social network clustering and the spread of HIV/AIDS among persons who inject drugs in two cities in the Philippines.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001485.
    PubMed     Text format     Abstract available

  27. SMOLDERS EJ, Smit C, Tmm De Kanter C, Dofferhoff A, et al
    High need to switch cART or co-medication with the initiation of DAAs in elderly HIV/HCV co-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001488.
    PubMed     Text format     Abstract available

  28. CLIFFORD KM, Samboju V, Cobigo Y, Milanini B, et al
    Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001489.
    PubMed     Text format     Abstract available

  29. HAWKINS C, Christian B, Fabian E, Macha I, et al
    HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001491.
    PubMed     Text format     Abstract available

  30. SINGH D, Ghate M, Godbole S, Kulkarni S, et al
    CD1d-Restricted Natural Killer T Cells Are Preserved in Indian Long-Term Nonprogressors.
    J Acquir Immune Defic Syndr. 2017;75:e104-e112.
    PubMed     Text format     Abstract available

  31. MCLEAN E, Price A, Chihana M, Kayuni N, et al
    Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.
    J Acquir Immune Defic Syndr. 2017;75:391-398.
    PubMed     Text format     Abstract available

  32. SMITH LR, Yore J, Triplett DP, Urada L, et al
    Impact of Sexual Violence Across the Lifespan on HIV Risk Behaviors Among Transgender Women and Cisgender People Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75:408-416.
    PubMed     Text format     Abstract available

  33. FLANDRE P, Marcelin AG, Calvez V
    Addition of Etravirine Does Not Enhance the Initial Decline of HIV-1 RNA in Treatment-Experienced Patients Receiving Raltegravir.
    J Acquir Immune Defic Syndr. 2017;75:448-454.
    PubMed     Text format     Abstract available

  34. DE LUCA A, Lorenzini P, Castagna A, Puoti M, et al
    Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75:465-471.
    PubMed     Text format     Abstract available


    J Infect Dis

  35. DELAUGERRE C, Antoni G, Mahjoub N, Pialoux G, et al
    Assessment of HIV Screening Tests for Pre-Exposure Prophylaxis Programs.
    J Infect Dis. 2017 Jun 27. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  36. DING X, Zhang X, Chong H, Zhu Y, et al
    Enfuvirtide (T20)-based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implication for Viral Entry and Inhibition.
    J Virol. 2017 Jun 28. pii: JVI.00831-17. doi: 10.1128/JVI.00831.
    PubMed     Text format     Abstract available

  37. ARIF MS, Hunter J, Leda AR, Zukurov JPL, et al
    The Pace of Co-receptor Tropism Switch in HIV-1 Infected Individuals after Recent Infection.
    J Virol. 2017 Jun 28. pii: JVI.00793-17. doi: 10.1128/JVI.00793.
    PubMed     Text format     Abstract available

  38. YU FH, Huang KJ, Wang CT
    Correction for Yu et al., "C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain".
    J Virol. 2017;91.
    PubMed     Text format    


    JAMA

  39. LYON J
    Hunt for an HIV Vaccine Intensifies.
    JAMA. 2017;317:2475.
    PubMed     Text format    


    Nature

  40. DESCOURS B, Petitjean G, Lopez-Zaragoza JL, Bruel T, et al
    Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Nature. 2017;546:686.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  41. NJOM NLEND AE, Nga Motaze A, Tetang Ndiang S, Fokam J, et al
    Predictors of Virological Failure on First-Line Antiretroviral Therapy among Children in a Referral Pediatric Center in Cameroon.
    Pediatr Infect Dis J. 2017 Jun 28. doi: 10.1097/INF.0000000000001672.
    PubMed     Text format     Abstract available

  42. SEERS T, Sarker D, Ross P, Heaton N, et al
    Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Co-Infection: A Case Report.
    Pediatr Infect Dis J. 2017 Jun 22. doi: 10.1097/INF.0000000000001662.
    PubMed     Text format     Abstract available

  43. KIRKPATRICK AR, Unsal AB, Blankson JN, Moore RD, et al
    Weak HIV Antibody Responses in Perinatally-Infected Young Adults.
    Pediatr Infect Dis J. 2017 Jun 23. doi: 10.1097/INF.0000000000001649.
    PubMed     Text format     Abstract available


    Pediatrics

  44. YBARRA ML, Prescott TL, Phillips GL 2nd, Bull SS, et al
    Pilot RCT Results of an mHealth HIV Prevention Program for Sexual Minority Male Adolescents.
    Pediatrics. 2017 Jun 28. pii: e20162999. doi: 10.1542/peds.2016-2999.
    PubMed     Text format     Abstract available


    PLoS Med

  45. TAYLOR M, Newman L, Ishikawa N, Laverty M, et al
    Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration.
    PLoS Med. 2017;14:e1002329.
    PubMed     Text format     Abstract available


    PLoS One

  46. KHOURY AL, Morey MC, Wong TC, McNeil DL, et al
    Diminished physical function in older HIV-infected adults in the Southeastern U.S. despite successful antiretroviral therapy.
    PLoS One. 2017;12:e0179874.
    PubMed     Text format     Abstract available

  47. DECKER S, Rempis E, Schnack A, Braun V, et al
    Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda.
    PLoS One. 2017;12:e0179448.
    PubMed     Text format     Abstract available

  48. GRACI JD, Michaels D, Chen G, Schiralli Lester GM, et al
    Identification of benzazole compounds that induce HIV-1 transcription.
    PLoS One. 2017;12:e0179100.
    PubMed     Text format     Abstract available

  49. RIDDLER SA, Husnik M, Ramjee G, Premrajh A, et al
    HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
    PLoS One. 2017;12:e0178594.
    PubMed     Text format     Abstract available

  50. WOLFF MJ, Giganti MJ, Cortes CP, Cahn P, et al
    A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.
    PLoS One. 2017;12:e0179769.
    PubMed     Text format     Abstract available

  51. ABEBE M, Ali I, Ayele S, Overbo J, et al
    Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0180078.
    PubMed     Text format     Abstract available

  52. ISHIZAKI A, Tran VT, Nguyen CH, Tanimoto T, et al
    Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.
    PLoS One. 2017;12:e0179616.
    PubMed     Text format     Abstract available

  53. MOSEPELE M, Hemphill LC, Moloi W, Moyo S, et al
    Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
    PLoS One. 2017;12:e0179994.
    PubMed     Text format     Abstract available

  54. HIGHTOW-WEIDMAN L, LeGrand S, Choi SK, Egger J, et al
    Exploring the HIV continuum of care among young black MSM.
    PLoS One. 2017;12:e0179688.
    PubMed     Text format     Abstract available

  55. LIN KY, Cheng CY, Li CW, Yang CJ, et al
    Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
    PLoS One. 2017;12:e0179870.
    PubMed     Text format     Abstract available

  56. WANDERA B, Tumwesigye NM, Nankabirwa JI, Kambugu AD, et al
    Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    PLoS One. 2017;12:e0180015.
    PubMed     Text format     Abstract available

  57. BRATTON E, Vannappagari V, Kobayashi MG
    Prevalence of and risk for gastrointestinal bleeding and peptic ulcerative disorders in a cohort of HIV patients from a U.S. healthcare claims database.
    PLoS One. 2017;12:e0180612.
    PubMed     Text format     Abstract available


    PLoS Pathog

  58. BOLTON DL, McGinnis K, Finak G, Chattopadhyay P, et al
    Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells.
    PLoS Pathog. 2017;13:e1006445.
    PubMed     Text format     Abstract available


    Science

  59. YU X, Jih J, Jiang J, Zhou ZH, et al
    Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150.
    Science. 2017;356.
    PubMed     Text format     Abstract available


    Vaccine

  60. VENEREO-SANCHEZ A, Simoneau M, Lanthier S, Chahal P, et al
    Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30801.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: